STRATEGIC ROUND TABLE MEETINGS 

EXECUTIVE ROUND TABLE HIGHLIGHTS

Global Market Entry & Technology Partnerships

International Tech-Transfer Forums (2024): Orchestrated high-level dialogues with CEOs and CTOs in Singapore and beyond.

Strategic Outcome: Forged cross-border co-development agreements and technology-transfer deals, accelerating global market expansion.

 National Governance & Institutional R&D Strategy

Industrial R&D Governance (2022-2023): Consulted with leadership from DRDO and AIIMS to develop tech-transfer performance metrics.

IP Compliance & Scaling (2021): Collaborated with MSME, Government of India, to engineer an IP governance framework for R&D scaling.

Strategic Outcome: Minimized legal exposure and established patents as primary growth levers for large-scale innovation hubs.

Deep-Tech & Med-Tech Product Lifecycle Strategy

Regulatory-Driven Development (2022): Partnered with Reckitt Benckiser (UK) to integrate global regulatory requirements into pharmaceutical device workflows.

Oncology & Bio-Tech Pipeline Strategy (2021): Facilitated sessions with experts from University of Calgary and Delhi University to fast-track high-barrier-to-entry medical products.

Strategic Outcome: Accelerated R&D cycles by mapping clinical research directly onto commercial product roadmaps.

Capital Infusion & Grant Strategy

Grant-Funded R&D Execution (2021): Designed capital-raising strategies with institutional leaders to align grant proposals with corporate priorities.

Strategic Outcome: Secured high-impact capital for R&D while ensuring zero misalignment between research goals and business ROI.

SELECT ENGAGEMENT ROSTER

Global Entities: Reckitt Benckiser (UK), University of Calgary, Singapore Tech Forums.

National Leaders: DRDO, AIIMS, ICMR, MSME (Govt of India), IIT, NIT.

Sector Focus: Defense-Tech, Healthcare/Pharma, Digital Health, and Industrial IP.